NCT05547334

Brief Summary

Adolescents with Obsessive-compulsive Disorder (OCD) have obsessions, compulsions or both. OCD is a severe psychiatric disorder, affecting many aspects of the lives of adolescents. The first choice treatment for adolescents with OCD is Cognitive Behavioral Therapy (CBT), consisting of exposure with response prevention (ERP) and cognitive interventions. Considering the substantial group of non-responders to CBT, it is necessary to have more options for effective treatment of OCD. Inference Based Approach (IBA) is already an effective treatment for adults with OCD and is more effective on adults with OCD and poor cognitive insight. It is hypothesized that IBA could be an effective alternative for CBT in treating adolescents with OCD. This study will be a first step in examining the efficacy of IBA as treatment for adolescents with OCD. The aim of this study is to explore the potential efficacy of IBA as treatment for adolescents with OCD using a non-concurrent multiple baseline design with 8 participants who receive IBA for 20 sessions performed in one psychiatric centre in the Netherlands.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2022

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 21, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

September 22, 2022

Status Verified

September 1, 2022

Enrollment Period

1 year

First QC Date

September 14, 2022

Last Update Submit

September 20, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in severity of OCD

    measured with the CY-BOCS at T0 = Study intake (baseline phase);T1 = Start treatment phase; i.e. start IBA treatment; T2 = Post-treatment assessment (after IBA treatment); T3 = Follow-up 3 months post-treatment

    through study completion, an average of 9 months

Secondary Outcomes (3)

  • Change in OCD symptomatology

    three-weekly questions during the intervention

  • Treatment history (psychotherapy and medication)

    T0 = Study intake (baseline phase)

  • Change in current medication use

    through study completion, an average of 9 months

Study Arms (1)

A non-concurrent multiple baseline design

OTHER

A non-concurrent multiple baseline design

Behavioral: Inference Based Approach (IBA)

Interventions

The Inference Based Approach (IBA) (as described by Visser et al., 2015 and adapted for use in adolescents by L. Webers)is a focused form of psychotherapy consists of twenty 45-minutes sessions, delivered weekly and carried out as specified in a Dutch session-by-session IBA protocol, containing standardized forms for exercises and homework assignments. Each session has a standard format, starting with agenda setting and evaluating homework assignments, followed by determining and executing a new exercise and determining new homework. The IBA model is based on the assumption that adolescents with OCD and poor inside misjudge the actual state of affairs. It is assumed that certain reasoning processes lead to these erroneous conclusions and distract the childs attention from observable reality.

A non-concurrent multiple baseline design

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Primary DSM-5 diagnosis of OCD. * A total score of 16 or higher on the CY-BOCS. * Age between 12 and 17;11. * A completed evidence-based treatment for OCD. * Medication must be stable for at least one month. A potential subject who meets any of the following criteria will be excluded from participation in this study: * No sufficient knowledge of the Dutch language * Autism spectrum disorder (ASD)\*\* * Mental retardation (TIQ\<80)\*\* * Acute suicidality (defined as having suicidal thoughts and plans and/or preparations to ending their life) * In case of ASD and/or mental retardation, the IBA protocol maybe too challenging. It is expected that the included cognitive elements, specifically when abstract reasoning is asked, will ask too much of these subjects.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Central Study Contacts

L.A.A.C. Webers, Msc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A non-concurrent multiple baseline design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 14, 2022

First Posted

September 21, 2022

Study Start

November 1, 2022

Primary Completion

November 1, 2023

Study Completion

November 1, 2024

Last Updated

September 22, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share